Valneva establishes an at-the-market (atm) program on nasdaq

Saint- herb lain (france ) , august 15 , 2 02 2 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that it has filed a prospectus supplement with the u.s. securities and exchange commission (“sec”) relating to an at-the-market offering (the “atm program”). pursuant to this new financing program, the company may offer and sell, including with unsolicited investors who have expressed an interest, a total gross amount of up to $75.0 million of american depositary shares (“ads”), each ads representing two of the company's ordinary shares, from time to time in sales deemed to be an “at the market offering” as defined in rule 415(a)(4) promulgated under the securities act of 1933, as amended, and pursuant to the terms of an open market sale agreement (the “sales agreement”) with jefferies llc (“jefferies”), acting as sales agent, subject to french regulatory limits. the timing of any sales will depend on a variety of factors and the company is not under any obligation to utilize the atm program in a specified amount or at all.
VALN Ratings Summary
VALN Quant Ranking